Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVIPREP Dosing Regimens for Colonoscopy
NCT01732692Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of macrogol in bowel preparation (2 arms), sponsored by Takeda. Primary endpoint: Percentage of Participants With Successful Colon Cleansing at Day 1. Started Nov 2012; status: completed.
02
Drugs
macrogol
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT01732692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732692.